As mentioned above, OGG1 depletion, or OGG1 inhibition, can rescue cells from lethality resulting from ROS-inducing agents; therefore, the role of OGG1 inhibitors in tumor therapy still needs to be further elucidated. Here, OGG1 is linked to neoplasm.